The Suprabasal Expression of α6ß4 Integrin Is Associated with a High Risk for Malignant Progression in Mouse Skin Carcinogenesis

Cancer Research

Volumn 53, Issue 20, 1993, Pages 4803-4810

  Tennenbaum, Tamar ^a   Weiner, Arin K ^a   Belanger, Adam J ^a   Glick, Adam B ^a   Hennings, Henry ^a   Yuspa, Stuart H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; INTEGRIN; KERATIN; TUMOR MARKER;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SKIN CARCINOGENESIS; SKIN TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; ANTIGENS, SURFACE; FEMALE; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6BETA4; KINETICS; MICE; MICE, INBRED STRAINS; PAPILLOMA; RISK FACTORS; SKIN; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TERPENES; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0027491154     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Boutwell, R. K. Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res., 4: 207-250, 1964.
2. Yuspa, S. H. and Poirier, M. C. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv. Cancer Res., 50: 25-70, 1988.
3. Shubik, P. The growth potentialities of induced skin tumors in mice. The effects of different methods of chemical carcinogenesis. Cancer Res., 10: 713-717, 1950.
4. Berenblum, I., and Shubik, P. The persistence of latent tumor cells induced in the mouse's skin by a single application of 9, 10-dimethyl-l, 2-benzanthracene. Br. J. Cancer, 3: 384-386, 1949.
5. Hennings, H., Spangler, E. F., Shores, R., Mitchell, P., Devor, D., Shamsuddin, A. K. M., Elgjo, K. M. and Yuspa, S. H. Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-I mice. Environ. Health Perspect., 68: 69-74, 1986.
6. Hennings, H., Shores, R., Wenk, M. L., Spangler, E. F., Tarone, R., and Yuspa, S. H. Malignant conversion of mouse skin tumors is increased by tumor initiators and unaffected by tumor promoters. Nature (Lond.), 304: 67-69, 1983.
7. Hennings, H., Shores, R., Mitchell, P., Spangler, E. F. and Yuspa, S. H. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis (Lond.), 6: 1607-1610, 1985.
8. Balmain, A., and Pragnell, I. B. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey ras oncogene. Nature (Lond.), 303: 72-74, 1983.
9. Balmain, A., Ramsden, M., Bowden, G. T. and Smith, J. Activation of the mouse cellular Harvey-ros gene in chemically induced benign skin papillomas. Nature (Lond.), 307: 658-660, 1984.
10. Huitfeldt, H. S., Heyden, A., Clausen, O. P. F., Thrane, E. V., Roop, D., and Yuspa, S. H. Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors. Carcinogenesis (Lond.), 12: 2063-2067, 1991.
11. Yuspa, S. H. Cellular and molecular changes during chemical carcinogenesis in mouse skin cells. In: E. Huberman and S. H. Barr (eds.), Carcinogenesis, pp. 201-209. New York: Raven Press, 1985.
12. Hennings, H., Glick, A. B., Greenhalgh, D. A., Morgan, D. L., Strickland, J. E., Tennenbaum, T., and Yuspa, S. H. Critical aspects of initiation, promotion and progression in multistage epidermal carcinogenesis. Proc. Soc. Exp. Biol. Med., 202: l-1, 1993.
13. Aldaz, C. M., Conti, C. J., Larcher, F., Trono, D., Roop, D. R., Chesner, J., Whitehead, T., and Slaga, T. J. Sequential development of aneuploidy, keratin modification and γ-glutamyltransferase expression in mouse skin papillomas. Cancer Res., 48: 3253-3257, 1988.
14. Roop, D. R., Krieg, T. M., Mehrel, T., Cheng, C. K. and Yuspa, S. H. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. Cancer Res., 48: 3245-3252, 1988.
15. Toftgard, R., Yuspa, S. H. and Roop, D. R. Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 45: 5845-5850, 1985.
16. Gimenez-Conti, I., Aldaz, C. M., Bianchi, A. B., Roop, D. R., Slaga, T. J. and Conti, C. J. Early expression of type I K13 keratin in the progression of mouse skin papillomas. Carcinogenesis (Lond.), 11: 1995-1999, 1990.
17. Nischt, R., Roop, D. R., Mehrel, T., Yuspa, S. H., Rentrop, M., Winter, H., and Schweizer, J. Aberrant expression during two-stage mouse skin carcinogenesis of type I 47-kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia. Mol., 1: 96-108, 1988.
18. Larcher, F., Bauluz, C. Diaz-Guerra, M., Quintanilla, M., Conti, C. J., Ballestin, C., and Jorcano, J. L. Aberrant expression of the simple epithelial type II keratin 8 by mouse skin carcinomas but not papillomas. Mol. Carcinog., 6: 112-121, 1992.
19. Conti, C. J., Aldaz, C. M. O'Connell, J. Klein-Szanto, A. J. P. and Slaga, T. J., Aneuploidy, an early event in mouse skin tumor development. Carcinogenesis (Lond.), 7: 1845-1848, 1986.
20. Aldaz, C. M., Trono, D., Larcher, F., Slaga, T. J. and Conti, C. J. Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol. Carcinog., 2: 22-26, 1989.
21. Bremner, R., and Balmain, A. Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell, 61: 407-417, 1990.
22. Hennings, H. Variable potential for malignant conversion of papillomas induced by initiation-promotion protocols. In: R., Langenbach, E., Elmore, and J. C. Barrett (eds.), Tumor Promoters: Biological Approaches for Mechanistic Studies and Assay Systems, pp. 31-37, New York: Raven Press, 1988.
23. Sonnenberg, A., Linders, C. J. T., Modderman, P. W., Damsky, C. H., Aumailley, M., and Timpl, R. Integrin recognition of different cell-binding fragments of laminin (PI, E3, E8) and evidence that αβ1 but not αβ4 functions as a major receptor for fragment E8. J. Cell Biol., 110: 2145-2155, 1990.
24. Kennel, S. J., Foote, L. J., Falcioni, R., Sonnenberg, A., Stringer, C. D., Crouse, C., and Hemler, M. E. Analysis of the tumor-associated antigen TSP-180. Identity with αβ4 in the integrin superfamily. J. Biol. Chem., 264: 15515-15521, 1989.
25. Roop, D. R., Cheng, C. K., Titterington, L., Meyers, C. A., Stanley, J. R., Steinert, P. M. and Yuspa, S. H. Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J. Biol. Chem., 259: 8037-8040, 1984.
26. Boiler, K., Kemler, R., Baribault, H., and Doetschman, T. Differential distribution of cytokeratins after microinjection of anti-cytokeratin monoclonal antibodies. Eur. J. Cell Biol., 43: 459-468, 1987.
27. Ruttenburg, A. M., Kim, H., Fischbein, J. W., Hanker, J. S., Wasserkrug, H. L. and Seligman, A. M. Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. J. Histochem. Cytochem., 17: 517-526, 1969.
28. Tennenbaum, T., Yuspa, S. H., Grover, A., Castronovo, V., Sobel, M. E., Yamada, Y., and De Luca, L. M. Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Cancer Res., 52: 2966-2976, 1992.
29. Van Waes, C., Kozarsky, K. F., Warren, A. B., Kidd, L., Paugh, D., Liebert, M., and Carey, T. E. The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin α6β4. Cancer Res., 57: 2395-2402, 1991.
30. Kennel, S. J., Foote, L. J. and Flynn, K. M. Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay. Cancer Res., 46: 707-712, 1986.
31. Liebert, M., Wedemeyer, G., Stein, J. A., Washington, J. R. W. Van Waes, C., Carey, T. E. and Grossman, H. B. The monoclonal antibody BQ16 identifies the αβ4 integrin in bladder cancer. Hybridoma, 12: 67-79, 1993.
32. Cooper, D., Schermer, A., and Sun, T. T. Biology of disease: classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab. Invest., 52: 243-256, 1985.
33. Leube, R. E., Bosch, F. X., Romano, V., Zimbelmann, R. Höfler, H., and Franke, W. W. Cytokeratin expression in simple epithelia. HI. Detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ. Differentiation, 33: 69-85, 1986.
34. Dale, B. A. and Holbrook, K. A. Developmental expression of human epidermal keratins and filaggrin. Dev. Biol., 22: 127-151, 1987.
35. Dale, B. A., Holbrook, K. A., Kimball, J. R., Hoff, M., and Sun, T. T. Expression of epidermal keratins and filaggrin during human fetal skin development. J. Cell Biol., 101: 1257-1269, 1985.
36. Moll, R., Moll, I., and Franke, W. W. Identification of Merkel cells in human skin by specific cytokeratin antibodies: changes of cell density and distribution in fetal and adult plantar epidermis. Differentiation, 28: 136-154, 1984.
37. Diaz-Guerra, M., Haddow, S., Bauluz, C., Jorcano, J. L., Cano, A., Balmain, A., and Quintanilla, M. Expression of simple epithelial cytokeratins in mouse epidermal keratinocytes harboring Harvey ras gene alterations. Cancer Res., 52: 680-687, 1992.
38. Miettinen, M. Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am. J. Pathol., 138: 505-513, 1991.
39. Bowden, P. E., Woodworth, C. D., Doniger, J., and DiPaolo, J. A. Down-regulation of keratin 14 gene expression after v-Ha-ras transfection of human papillomavirus-immortalized human cervical epithelial cells. Cancer Res., 52: 5865-5871, 1992.
40. Fernandes, C., and Rao, K. V. Enhanced expression of low molecular weight keratins during progressive diethylnitrosamine-induced hepatocarcinogenesis in rats is associated with the presence of high levels of γ-glutamyl transpeptidase and glycogen-deficient islands. Cancer Lett., 59: 211-219, 1991.
41. Marceau, N. Biology of disease: cell lineages and differentiation programs in epidermal, urothelial and hepatic tissues and their neoplasms. Lab. Invest., 63: 4-20, 1990.
42. Markey, A. C., Lane, E. B., Churchill, L. J., MacDonald, D. M. and Leigh, I. M. Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. J. Invest. Dermatol., 97: 763-770, 1991.
43. Smedts, F., Ramaekers, R., Troyanovsky, S., Pruszczynski, M., Link, M., Lane, B., Leigh, I., Schijf, C., and Vooijs, P. Keratin expression in cervical cancer. Am. J. Pathol., 141: 497-511, 1992.
44. Smedts, R., Ramaekers, R., Robben, H., Pruszczynski, M., van Muijen, G., Lane, B., Leigh, I., and Vooijs, P. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am. J. Pathol., 136: 657-668, 1990.
45. Wetzels, R. H., Schaafsma, H. E., Leigh, I. M., Lane, E. B., Troyanovsky, S. M., Wagenaar, S. S., Vooijs, G. P. and Ramaekers, F. C. Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17 and 18. Histopathology, 20: 295-303, 1992.
46. Bocker, W., Bier, B., Freytag, G., Brommelkamp, B., Jarasch, E. D., Edel, G. Dockhorn-Dworniczak, B., and Schmid, K. W. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, α-smooth muscle actin, vimen-tin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ. Virchows Arch. A Pathol. Anat. Histopathol., 421: 323-330, 1992.
47. Gel'shtein, V. I., Chipysheva, T. A., Ermilova, V. D. and Liubimov, A. V. Monoclonal antibodies to the proteins of intermediate filaments and of basement membranes in the differential diagnosis of certain forms of human breast tumors. Arkh. Patol., 52: 12-18, 1990.
48. Ferrero, M., Spyratos, R. Le Doussal, V., Desplaces, A., and Rouesse, J. Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors. Cytometry, 11: 716-724, 1990.
49. Hurlimann, J., and Gardiol, D. Immunohistochemistry in the differential diagnosis of liver carcinomas. Am. J. Surg. Pathol., 15: 280-288, 1991.
50. Ganjei, P., Giraldo, K. A., Lampe, B., and Nadji, M. Vulvar Paget's disease. Is immunocytochemistry helpful in assessing the surgical margins? J. Reprod. Med., 35: 1002-1004, 1990.
51. Cheng, C., Kilkenny, A. E., Roop, D., and Yuspa, S. H. The v-ras oncogene inhibits the expression of differentiation markers and facilitates expression of cytokeratins 8 and 18 in mouse keratinocytes. Mol. Carcinog., 3: 363-373, 1990.
52. Glick, A. B., Sporn, M. B. and Yuspa, S. H. Altered regulation of TGF-β 1 and TGF-α in primary keratinocytes and papillomas expressing v-Ha-ras. Mol. Carcinog., 4: 210-219, 1991.
53. Hashimoto, Y., Tajima, O., Hashiba, H., Nose, K., and Kuroki, T. Elevated expression of secondary, but not early, responding genes to phorbol ester tumor promoters in papillomas and carcinomas of mouse skin. Mol. Carcinog., 3: 302-308, 1990.
54. Reiss, M., Stash, E. B., Vellucci, V. F. and Zhou, Z. L. Activation of the autocrine transforming growth factor a pathway in human squamous carcinoma cells. Cancer Res., 57: 6254-6262, 1991.
55. Glick, A. B., Kulkarni, A. B., Tennenbaum, T., Hennings, H., Flanders, K. C. O'Reilly, M., Sporn, M. B., Karlsson, S., and Yuspa, S. H. Loss of TGF-β expression in mouse epidermis and epidermal tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc. Natl. Acad. Sci. USA, 90: 6076-6080, 1993.
56. Heino, J., and Massague, J. Transforming growth factor-β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J. Biol. Chem., 264: 21806-21811, 1989.
57. Santala, P., and Heino, J. Regulation of integrin-type cell adhesion receptors by cytokines. J. Biol. Chem., 266: 23505-23509, 1991.
58. Sheppard, D., Cohen, D. S., Wang, A., and Busk, M. Transforming growth factor β differentially regulates expression of integrin subunits in guinea pig airway epithelial cells. J. Biol. Chem., 267: 17409-17414, 1992.
59. Kaufmann, W. K., Zhang, Y., and Kaufman, D. G. Association between expression of transforming growth factor-α and progression of hepatocellular foci to neoplasms. Carcinogenesis (Lond.), 13: 1481-1483, 1992.
60. Hashido, K., Morita, T., Matsushiro, A., and Nozaki, M. Gene expression of cytokeratin endo A and endo B during embryogenesis and in adult tissues of mouse. Exp. Cell Res., 792: 203-212, 1991.
61. Trevor, K., and Oshima, R. G. Preimplantation mouse embryos and liver express the same type I keratin gene product. J. Biol. Chem., 260: 15885-15891, 1985.
62. Jackson, B. W., Grand, C., Schmid, E., Burki, K., Franke, W. W. and Illmensee, K. Formation of cytoskeletal elements during mouse embryogenesis. Differentiation, 17: 161-179, 1980.
63. Sengel, P. Epidermal-dermal interaction. In: J. Bereiter-Hahn, A. G., Matoltsy, and K. S. Richards (eds.), Biology of the Integument, Vol. 2, pp. 374-408. New York: Springer- Verlag, 1984.
64. De Young, L. M., Richards, W. L., Bonzelet, W., Tsai, L. L. and Boutwell, R. K. Localization and significance of γ-glutamyltranspeptidase in normal and neoplastic mouse skin. Cancer Res., 38: 3697-3701, 1978.
65. Weinberg, W. C., Goodman, L. V., George, C., Morgan, D. L., Ledbetter, S., Yuspa, S. H. and Lichti, U. The reconstitution of hair follicle development in vivo: determination of follicle formation, hair growth and hair quality by dermal cells. J. Invest. Dermatol., 100: 229-236, 1993.